- Home
- NEWS
2024
-
- patent2024/02/13
-
- China National Intellectual Property Administration Grants AskAt a Patent for AAT-730 Salt & Crystal Forms
- AskAt received a Notice of Allowance dated February 4, 2024 from the China National Intellectual Property Administration (CNIPA) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Chinese Patent Application No. 202180063678.2 (Filing Date: November 11, 2021).
-
- patent2024/02/02
-
- Canadian Intellectual Property Office Grants AskAt a Patent for AAT-730 Salt & Crystal Forms
- AskAt received a Notice of Allowance dated January 25, 2024 from the Canadian Intellectual Property Office (CIPO) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Canadian Patent Application No. 3,196,706 (Filing Date: November 11, 2021).
-
- patent2024/02/01
-
- Korean Intellectual Property Office Grants AskAt a Patent for AAT-730 Salt & Crystal Forms
- AskAt received a Notice of Allowance dated January 24, 2024 from the Korean Intellectual Property Office (KIPO) for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Korean Patent Application No. 10-2023-7017249 (Filing Date: November 11, 2021).
-
- patent2024/01/26
-
- Intellectual Property India Grants AskAt a Patent for the Use of EP4 Receptor Antagonists in the Treatment of NASH-Associated Liver Cancer
- AskAt received a Letters Patent dated January 4, 2024 for a use patent for its EP4 receptor antagonist in the treatment of NASH-associated liver cancer. The Notice was issued by the Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) in connection with Indian Patent Application No. 201827020731.0 (Filing Date: November 2, 2017).
-
- patent2024/01/17
-
- Intellectual Property India Grants AskAt a Patent for AAT-076 Formulation
- AskAt received a Letters Patent dated December 14, 2023 for a formulation patent for AAT-076, its COX-2 inhibitor. The Notice was issued by the Office of the Controller General of Patents, Designs & Trade Marks (CGPDTM) in connection with Indian Patent Application No. 641/MUMNP/2014 (Filing Date: October 18, 2012).
-
- patent2024/01/17
-
- Japan Patent Office Grants AskAt a Patent for the AAT-730 Salt & Crystal
- AskAt received an Official Decision of Grant from the Japan Patent Office dated January 9, 2024 for a salt and crystal forms patent for the company’s CB2 agonist, AAT-730. The notice was issued in connection with Japanese Patent Application No. 2023-528364 (Filing Date: November 11, 2021).
- NEWS
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2013